Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Tables)

v3.20.1
Share Capital (Tables)
 12 Months Ended
Dec. 31, 2019
Statement Line Items [Line Items]  
Schedule of outstanding and exercisable options

December 31, 2019  
Options outstanding     Options exercisable  
      Number of     Weighted     Number of     Weighted  
      options     average     options     average  
      outstanding     remaining     exercisable     remaining  
Exercise     at end of     contractual     at end of     contractual  
prices *     year     Life     year     life  
60.5       6,998       0.85       6,998       0.85  
26.04       6,666       5.38       1,329       5.38  
6.37       5,000       5.34       1,875       5.34  
5.07       248,000       6.09       -       -  
4.02       478,361       5.03       310,093       4.94  

 

* In U.S. dollars per Ordinary Share.
Schedule of share-based compensation

    Year ended December 31  
    2019     2018     2017  
Research and development expenses   $ 549     $ 457     $ 333  
General, administrative and marketing expenses     576       977       623  
    $ 1,125     $ 1,434     $ 956  
Option Granted to Employees [Member]  
Statement Line Items [Line Items]  
Schedule of number of shares issued granted options

    Year ended December 31, 2019
    Award amount     Exercise price range     Vesting period   Expiration
Employees     230,000     $ 5.07     4 years   7 years
Directors     301,390     $ 4.02- $5.07     4 years   7 years

 

    Year ended December 31, 2018
    Award amount     Exercise price range*     Vesting period   Expiration
Employees     93,000     $ 5.87     4 years   7 years
Directors     63,000     $ 7.74     4 years   7 years

 

    Year ended December 31, 2017
    Award amount    

Exercise price

range*

     Vesting period   Expiration
Employees     182,000     $ 8.34     4 years   7 years
Directors     9,720     $ 0- $4.75     0-4 years   7 years

 

  * Exercise price range before reduction of exercise price as of October 27, 2019
Schedule of fair value options granted

    2019     2018     2017  
Value of one ordinary share   $

5.7-$5.93

     $

5.34-$7.83

     $

4.89-$7.44

  
Dividend yield     0 %     0 %     0 %
Expected volatility     61.31%-62.56 %     62.63 %     57.78 %-62.55 %
Risk-free interest rate     2 %     2 %     2 %
Expected term     4-5.5 years       4 years       4 years  

 
Schedule of changes in number of options granted

    Year ended December 31,  
    2019     2018     2017  
    Number of options     Weighted average exercise price     Number of options     Weighted average exercise price*     Number of options     Weighted average exercise price*  
Options outstanding at the beginning of the year     512,615     $ 15.09       385,115     $ 17.68       205,592     $ 27.10  
Granted     531,390       5.09       156,000       7.55       191,720       8.07  
Exercised     (6,076 )     1.30       -       -       -       -  
Expired     (11,891 )     23.83       (2,500 )     24.01       (7,102 )     24.89  
Forfeited     (304,677 )     5.84       (26,000 )     7.42       (5,095 )     25.96  
Options outstanding at the end of the year     721,361     $ 4.38 *     512,615     $ 15.09       385,115     $ 17.68  
Options exercisable at the end of the year     310,093     $ 4.02 *     211,906     $ 20.28       131,265     $ 22.29  

 

 

* After repricing- see Note 8(B)(2)(a).
Option Granted to Non-Employees [Member]  
Statement Line Items [Line Items]  
Schedule of fair value options granted

    2019     2018     2017  
Value of one ordinary share   $ 5.93     $ 5.36           -  
Dividend yield     0 %     0 %     -  
Expected volatility     62 %     58 %     -  
Risk-free interest rate     2 %     2 %     -  
Expected term     4 years       4 years       -  
Schedule of changes in number of options granted

    Year ended December 31  
    2019     2018     2017  
    Number of
options		     Weighted average exercise
price		     Number of
options		     Weighted average exercise
price*		     Number of
options		     Weighted average exercise
price*		  
Options outstanding at the beginning of the year     18,664     $ 33.44       13,664     $ 43.52       13,664     $ 43.52  
Granted     5,000       5.07       5,000       5.87       -       -  
Options outstanding at the end of the year     23,664     $ 27.44       18,664     $ 33.44       13,664     $ 43.52  
Options exercisable at the end of the year     10,202     $ 46.03       8,165     $ 51.21       7,831     $ 52.57